MedTrace Logo

Exogenous Ketone Supplementation and Exercise Performance

NCT03895892 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-10-02

No results posted yet for this study

Summary

20 healthy recreationally active men and woman aged 18-35 will participate in the study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. The three main trials will be separated by at least 1 week. After providing the corresponding treatment, participants will be given 30 minutes and after, they will perform a standardized 10-minute warm-up, followed by the 20 km time trial and a 30-second all-out Wingate test.

Conditions

  • Ketonemia
  • Ketosis

Interventions

BEHAVIORAL

20 km time trial

20 km time trial cycling test will be conducted to measure the effect of different drinks on time

BEHAVIORAL

Wingate test

30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output

DIETARY_SUPPLEMENT

Ketone/Caffeine

Dietary supplement containing ketone salts and caffeine

DIETARY_SUPPLEMENT

Ketone

Dietary supplement containing only ketone salts

DIETARY_SUPPLEMENT

Water Placebo

Dietary supplement containing only water

Sponsors & Collaborators

  • Western University, Canada

    lead OTHER

Principal Investigators

  • Peter Lemon, PhD · Western University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03895892 on ClinicalTrials.gov